A Clinical Study Comparing the Comfort of Three Commercially Available Contact Lenses
NCT ID: NCT02298400
Last Updated: 2024-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2014-08-31
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Comparison of Three Contact Lens Care Systems and Their Effect on Contact Lenses
NCT00982046
Clinical Evaluation of 3 Contact Lens Materials With 3 Solution Types
NCT03466060
Clinical Study of Approved and Investigational Contact Lenses
NCT02708524
Clinical Evaluation of an Investigational Soft Contact Lens
NCT01254747
Air Optix Daily Wear Contact Lenses
NCT05827224
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acuvue®Oasys® Lenses(senofilcon A)
Acuvue® Oasys® Lenses (senofilcon A) contact lenses
Acuvue® Oasys® Lenses (senofilcon A)
Contact lenses placed in each eye during the day for about 8 hours
30-Day Bausch + Lomb PureVision (balafilcon A)
Contact lenses placed in each eye during the day for about 8 hours
Clariti® 1-Day (Somofilcon A)
Contact lenses placed in each eye during the day for about 8 hours
Bausch + Lomb PureVision (balafilcon A)
30-Day Bausch + Lomb PureVision (balafilcon A) contact lenses
Acuvue® Oasys® Lenses (senofilcon A)
Contact lenses placed in each eye during the day for about 8 hours
30-Day Bausch + Lomb PureVision (balafilcon A)
Contact lenses placed in each eye during the day for about 8 hours
Clariti® 1-Day (Somofilcon A)
Contact lenses placed in each eye during the day for about 8 hours
Clariti® 1-Day (Somofilcon A)
Clariti® 1-Day (Somofilcon A) contact lenses
Acuvue® Oasys® Lenses (senofilcon A)
Contact lenses placed in each eye during the day for about 8 hours
30-Day Bausch + Lomb PureVision (balafilcon A)
Contact lenses placed in each eye during the day for about 8 hours
Clariti® 1-Day (Somofilcon A)
Contact lenses placed in each eye during the day for about 8 hours
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acuvue® Oasys® Lenses (senofilcon A)
Contact lenses placed in each eye during the day for about 8 hours
30-Day Bausch + Lomb PureVision (balafilcon A)
Contact lenses placed in each eye during the day for about 8 hours
Clariti® 1-Day (Somofilcon A)
Contact lenses placed in each eye during the day for about 8 hours
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have provided written informed consent
* Have discomfort when wearing contact lenses
Exclusion Criteria
* Participated in any other studies in the past 30 days
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ORA, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Andover Eye Associates
Andover, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-270-0001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.